HEAT ALERT

Extreme heat blankets the region starting tomorrow and could last until next week

Regeneron: Antibody cocktail cut COVID-19 death risk in half for hospitalized patients

Tarrytown's Regeneron presented some promising data Tuesday from its antibody cocktail.

News 12 Staff

Dec 30, 2020, 3:31 AM

Updated 1,265 days ago

Share:

Tarrytown's Regeneron presented some promising data Tuesday from its antibody cocktail.
According to its own research, the company's antibody cocktail cut the risk of death by 50% in patients currently in the hospital that require low-flow oxygen.
Initial data showed it had to be used in non-hospitalized patients only.
Last month, the FDA granted an emergency-use authorization for the antibody cocktail.


More from News 12